STML
Stemline Therapeutics, Inc.
STML
STML
Delisted
STML was delisted on the 9th of June, 2020.
91 hedge funds and large institutions have $303M invested in Stemline Therapeutics, Inc. in 2018 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 33 increasing their positions, 20 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
91
Holders Change
+9
Holders Change %
+10.98%
% of All Funds
2.09%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
23
Increased
33
Reduced
20
Closed
14
Calls
$330K
Puts
$3.44M
Net Calls
-$3.11M
Net Calls Change
-$1.25M
Top Buyers
| 1 |
1
BlackRock
New York
|
$29.7M |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$13.2M |
| 3 |
3
Two Sigma Investments
New York
|
$3.85M |
| 4 |
LSC
4
Lyon Street Capital
Sausalito,
California
|
$23.6M |
| 5 |
5
State Street
Boston,
Massachusetts
|
$16.8M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
SI
101
Sofinnova Investments
Menlo Park,
California
| – | -$193K | -12,640 | Closed |
|
|
RA
102
Royce & Associates
New York
| – | -$104K | -6,800 | Closed |
|
|
PAM
103
Panagora Asset Management
Boston,
Massachusetts
| – | -$25K | -1,640 | Closed |
|
104
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| – | -$23K | -1,500 | Closed |
|
|
MAM
105
Meeder Asset Management
Dublin,
Ohio
| – | -$1K | -90 | Closed |
|